Crossref
Amitriptyline at low dose for burning mouth syndrome
Oral Diseases · 2024
DOI: 10.1111/odi.14966 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, 2024. Verfasst von Takahiko Nagamine. Beteiligte Einrichtung: Department of Psychiatric Internal Medicine, Sunlight Brain Research Center, Hofu, Yamaguchi, Japan. Hauptthemen laut MEDLINE: Burning Mouth Syndrome, Amitriptyline. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Burning Mouth SyndromeAmitriptylineHumansAnalgesics, Non-NarcoticFemaleMiddle AgedMale
Stichwörter der Autor:innen
amitriptylineburning mouth syndromedefault mode networkdescending pain inhibitory pathwayirritable bowel syndromeserotonin
Substanzen
AmitriptylineAnalgesics, Non-Narcotic
Autor:innen und Institutionen
- Department of Psychiatric Internal Medicine, Sunlight Brain Research Center, Hofu, Yamaguchi, Japan.
- Department of Psychosomatic Dentistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
ORCID-Profile: Takahiko Nagamine
Zitieren
APA
Nagamine, T. (2024). Amitriptyline at low dose for burning mouth syndrome. Oral Diseases. https://doi.org/10.1111/odi.14966
Vancouver
Nagamine T. Amitriptyline at low dose for burning mouth syndrome. Oral Diseases. 2024. doi:10.1111/odi.14966
BibTeX
@article{Nagamine2024,
author = {Nagamine, Takahiko},
title = {Amitriptyline at low dose for burning mouth syndrome},
journal = {Oral Diseases},
year = {2024},
doi = {10.1111/odi.14966}
}
EUVIMED